HIV EXPLORATORY RSCH

Abstract

This project funds research on the human immunodeficiency virus (HIV), which causes Acquired Immunodeficiency Syndrome (AIDS). Work in this area includes developing improved identification methods to determine genetic diversity of the virus, and evaluating and preparing overseas sites for future vaccine trials. Additional activities include developing candidate vaccines for preventing HIV and undertaking preclinical studies (studies required before testing in humans) to assess vaccine for potential to protect and/or manage the disease in infected individuals. This program is jointly managed through an Interagency Agreement between the US Army Medical Research and Materiel Command and the National Institute of Allergy and Infectious Diseases of the National Institutes of Health. This project contains no duplication of effort within the Military Departments or other government organizations. Work is related to and fully coordinated with work funded in PE 0603105A, project H29. The cited work is consistent with the Director, Defense Research and Engineering Strategic Plan, the Army Modernization Strategy, and the Army Science and Technology Master Plan. Work in this project is performed by the Walter Reed Army Institute of Research (WRAIR) and the Naval Medical Research Center (NMRC), Silver Spring, MD, and their overseas laboratories. The Henry M. Jackson Foundation (HMJF), located in Rockville, MD provides support for FDA testing and other research under a cooperative agreement.

Open PDF

Document Details

Document Type
Project
Publication Date
Oct 01, 2012
Source ID
873_0602787A_2_2040_PB_2012

Tags

Readers

  • Defense Technology Research and Development.
  • Infectious Disease/Epidemiology
  • Military Science and Technology Research and Modernization.

Technology Areas

  • Biotechnology

Related Documents